Defying hATTR-PN challenges:
A guide to building control
Overcome hATTR-PN obstacles by learning how genetic testing supports diagnosis, how to monitor and communicate symptoms, build the right care team, confidently lead conversations about your treatment goals, and more.
Watch: Turning the tide
Read: A guide to building control
Living with hATTR-PN means navigating complex treatment decisions while balancing symptoms, daily life, and long-term priorities. Clearly defining and revisiting your treatment goals can help guide focused, collaborative conversations with your care team.
hATTR-PN can affect many parts of the body, making coordinated, team-based care essential. Learn how a multidisciplinary care team can support your health, manage symptoms, and help you feel more supported day to day.
Monitoring early hATTR-PN symptoms: A guide to effective communication
Fact-Checked By PatrÃcia Silva, PhD
Recognizing early hATTR-PN symptoms and tracking changes over time can help you and your care team make more informed decisions about diagnosis and treatment. Early awareness may support timely intervention and better long-term management of this progressive condition.
Talking about hATTR-PN with the people closest to you can help them better understand what you’re living with and how to support you day to day. Starting these conversations gradually can ease the emotional weight and build understanding over time.
Physical therapy can play an important role in helping you move more safely and confidently while living with hATTR-PN. With the right support, it can help you maintain mobility, manage symptoms, and adapt as your movement needs change over time.
Genetic testing plays a central role in confirming an hATTR-PN diagnosis and guiding treatment, family screening, and long-term care decisions. Early testing can help slow disease progression and protect nerve function before irreversible damage occurs.
Recent Posts
- Scientists ID blood markers that predict heart risk in ATTR-CM
- Navigating amyloidosis treatment can be challenging for older adults
- Tiny skin biopsies may help diagnose transthyretin amyloidosis: New study
- Early diagnosis, treatment improves survival in ATTR-CM: Study
- FDA lifts clinical hold on Phase 3 trial of nex-z for hATTR-PN